IDEA Initiative hosts new practicum & internship opportunities for JHSPH master's students
Access to Medicines Practicum & Internship Cluster
November 16, 2017
The IDEA (Innovation + Design Enabling Access) Initiative has developed a cluster of practicums and internships centered around the theme of Access to Medicines for master's students at the Johns Hopkins Bloomberg School of Public Health. These practicum projects and internships are an opportunity for Bloomberg School students to learn from and network with the other students in the cluster as well as our partners in the various organizations hosting student projects. The practicum & internship cluster on Access to Medicines covers topics ranging from drug pricing to antibiotic resistance. Comprised of projects housed in a network of organizations, this cluster will allow students to gain valuable work experience while seeing how their individual project fits within a network of initiatives that together work to improve access to medicines. Students participating in this cluster will have the opportunity to meet regularly with the other students and learn from each of the inspiring preceptors through regular discussion sessions, lunches and seminars. In addition to their project specific responsibilities, students will participate in monthly cluster-related activities with the other students in the cluster and with onsite or remote participation by each of the partner organization preceptors. Anthony D. So, MD, MPA will be the JHSPH faculty member overseeing the cluster and acting as secondary preceptor for the projects. We are aiming for about 5 related activities, for a total of 5-8 hours over the course of the practicum/internship experience, which, in the case of the practicum, will count towards the required hours for completion.
Available opportunities | Application deadline: December 15, 2017
- Stopping the Overuse of Antibiotics, a Multi-Pronged Approach—US Public Interest Research Group (US PIRG):
Stop the overuse of antibiotics through healthcare professional engagement and advocacy. Help develop a healthcare professional action kit and organize advocacy workshops.
- Combating antibiotic resistance in rural communities: building a case for antibiotic stewardship based on health self-interest – Center for Science in the Public Interest (CSPI), Regulatory Affairs Department
Work on a report outlining the impact of antibiotic resistance on rural communities, including access to quality care at rural hospitals, relative disease burden, and personal stories of rural families and farm workers who have experienced drug resistant infections.
- Updating Public Citizen’s seminal “R&D Myths” report—Public Citizen
Help Public Citizen debunk some of the myths associated with R&D spending by pulling together the information and writing the new “R&D Myths” report based on findings from research, joint briefings and conversations with stakeholders on drug pricing and innovation.
- Medicines accessibility and affordability through NIH global access licensing—Universities Allied for Essential Medicines (UAEM)
Assist UAEM in its campaign urging NIH to the strengthen conditions it attached to university grants to help ensure their accessibility and affordability via global access licensing, by conducting a survey among JHU faculty carrying out NIH grants.
- Sutezolid: A case study in ensuring access to a novel TB medication through university licensing—Universities Allied for Essential Medicines (UAEM)
Focus on research, writing and communications for public health to build a case study of the UAEM-led Treatment Action Group (TAG), which won a campaign in 2016 to Johns Hopkins University (JHU) to license a promising tuberculosis drug, Sutezolid, to the Medicines Patent Pool (MPP).
- Promoting policy coherence to increase affordable access and innovation to health technologies within the Agenda 2030—United Nations Development Program (UNDP):
By organizing meetings and briefings with experts and UN member states and conducting research to support issue briefs, external publication and strategy development, support the UNDP mandate and work-program to increase affordable access and innovation to health technologies in developing countries within the Agenda 2030 Sustainable Development Goals (SDGs).
- Organize Maryland-based 2018 drug pricing reform efforts—Public Citizen
Aid Public Citizen in its effort to reform state-level drug pricing policy by leading efforts in Maryland by leading outreach efforts and hosting and attending conversations with health and academic communities.
- Ensuring Prescription Drug Affordability in Maryland—Maryland Citizens’ Health Initiative (MCHI)
Develop prescription drug policy, educate the public, and enact public policy to positively impact citizens of Maryland through policy and messaging development, media outreach, on-the-ground legislative education of elected officials, and community organizing.
- Minimizing Antibiotic Resistance in the Global Food Chain: Researching Country Policies and Positions and Educating Delegates Developing a Codex Code of Practice on Antibiotic Use in Agriculture Consumers Union—(CU): Research relevant national policies of major nations around the world as to how they regulate or restrict antibiotic use on crops and on food animals, as well as gather other relevant information, in order to create a strong basis for educating nations and citizen groups about key items to include in the Codex Code of Practice, and achieving consensus on a Code.
To learn more about the projects and apply, visit the Practicum Opportunity Site and search "Access to Medicines."
The IDEA Initiative was launched in 2016 by Anthony D. So, MD, MPA, a professor of the practice in International Health at the Johns Hopkins Bloomberg School of Public Health. The IDEA Initiative fosters innovation and the design of new technologies for greater health access and impact through a combination of research, policy work and training. It also collaborates with a variety of initiatives across the Johns Hopkins University and beyond. These include the Johns Hopkins Alliance for a Healthier World and ReAct - Action on Antibiotic Resistance.